Serologic analyses and virus isolation studies were carried out to determine the role of bovid herpesvirus-4 (BHV-4) in infections in cattle, principally those of the reproductive tract. Serologic analyses were performed, using an indirect fluorescent antibody test on thoracic fluid specimens from aborted fetuses and on sera from 3 sources of adult cattle. Virus isolation was attempted from field cases of abortion, early embryo death, and postpartum vulvovaginitis/metritis, using uterine discharge and buffy coat preparations obtained from cows and tissues obtained from aborted fetuses. Of 420 fetal thoracic fluid specimens examined, 5 were positive for BHV-4 antibodies. Seventeen percent of adult cattle from 2 sources ie, clinically normal herds and abattoir cattle, were seropositive for BHV-4 antibodies. Cattle from a third source, 4 herds with high incidence of reproductive tract disorders, had a seroprevalence rate between 36 and 88%. Two isolates of BHV-4 were also obtained from this group. the overall incidence of BHV-4 antibodies in clinically normal cattle was higher than previously recognized, with relatively higher prevalence in herds having reproductive problems (chi-squared = 156.5, P less than 0.005). At least 10% of the BHV-4 antibody-positive sera did not have neutralizing antibody against bovine viral diarrhea virus and/or bovid herpesvirus-1, both important causes of bovine reproductive tract disorders.

Urinary protein loss was determined in 12 healthy cats. Voided urine was collected and protein quantitated by the Coomassie blue method. Mean protein loss for all cats was 12.65 mg/kg24 h (5.45 SD). Protein loss for male cats (n=6) was 16.62 mg/kg24 h (3.3 SD), which was significantly different (P less than 0.01) from 8.69 mg/kg/24 h (4.09 SD) for females (n = 6). A single urine protein-creatinine ratio correlated well with the total urinary protein loss in mg/kg/24 h. The correlation coefficient for the protein-creatinine ratio in voided urine (UPCV) vs 24-hour urinary protein (UP-24) loss was 0.968, and that for the protein-creatinine ratio in urine obtained by cystocentesis (UPCC) vs UP-24 was 0.945. The regression equations were UPCV = 0.02145 + 0.02338 x UP-24 (mg/kg), and UPCC = 0.02667 + 0.02133 x UP-24 (mg/kg). Using the mean value plus 3 SD of urinary protein loss from the healthy cats in this study, a healthy cat would be expected to have a urinary protein loss of less than 29 mg/kg/24 h. A protein-creatinine ratio from a single urine sample provides an accurate estimate of urinary protein loss in healthy cats.

An ELISA was developed to measure serum concentratrions of tetanus toxoid-specific immunoglobulins. The titers obtained with this assay were compatible with those obtained by the standard mouse toxin-neutralization test. Serum samples from 123 llamas were analyzed for ELISA titers to tetanus toxoid. Of the 82 vaccination adults, 75 (91%) had titers greater than or equal to 1:50. The vaccination status and titers of weanlings and juveniles (3 to 12 months old) varied; of the 21 vaccinated, 17 (81%) had titers greater than or equal to 1:50 and 7 of 9 (78%) unvaccinated llamas had titers less than 1.50. The ELISA titers of unvaccinated llamas less than 8 weeks old (crias) were matched with the maternal titers. All crias with titers less than 1:50 had dams with titers greater than or equal to 1:50.

High-speed cinematography was used to record the movements of 12 cutting horses performing a standard test with a mechanical flag. Based on their previous competitive performances, horses were classified into 2 groups: group 1, composed of 5 moderately successful or average performers that had won less than $35,000 in purse money; and group 2, composed of 7 highly successful or elite performers that had amassed greater than $35,000 in competition earnings. Analysis of the results indicated that, compared with horses of the average group, the elite horses had faster reaction times in response to the start and cessation of flag movement (P less than 0.01), and were positioned closer to the flag during all stages of the trial (P less than 0.05). Discriminant analysis was used to construct a mathematical formula that could be used to classify an individual horse into 1 of the 2 alternative groups, based on the set of measurements. Two predictor variables were selected that described the maximal distance between the horse and the flag during the run and the part of the body that was moved first in response to the initial flag movement. The accuracy of the predicted group membership, compared with the actual group membership, was 100%.

The effect of aspirin on bovine platelet function and thromboxane A2 (TXA2) production in stimulated platelets was evaluated. A single dose of aspirin (100 mg/kg of body weight) was administered orally to Holstein cows, and blood samples were obtained before and at regular intervals for 7 days after treatment. The production of TXA2 was assessed by measuring the stable metabolite thromboxane B2, using a specific radioimmunoassay. Within 4 hours of aspirin administration, the production of TXA2 was significantly (P less than 0.05) decreased, irrespective of whether collagen, adenosine diphosphate, or platelet activating factor was used to initiate platelet aggregation. Despite the inhibition of TXA2 release from the stimulated platelets, platelet function, assessed by initial rate of aggregate formation and extent of aggregation, was unaffected by aspirin administration. The extent of aggregate formation in response to collagen, adenosine diphosphate, or platelet activating factor was independent of the amount of TXA2 released from platelets before and after aspirin treatment. The results suggested that TXA2 formation is not the primary biochemical pathway involved in the aggregation of stimulated bovine platelets.

A clinical trial examining the efficacy of 2 drugs for treatment of a natural epizootic of infectious bovine keratoconjunctivitis was performed. The study was conducted in 103 grazing Hereford calves during the summer of 1985. The calves were prospectively and randomly assigned to 1 of 3 groups at the beginning of the study on June 17, and were examined 3 times weekly thereafter until the final observation on August 6. Calves in group 1 (n = 34) were not treated and were used as controls. Calves of group 2 (n = 34) with corneal ulcers were treated with a long-acting oxytetracycline formulation (OTC group). The parenteral treatment was repeated in 72 hours. Affected calves of group 3 (n = 35) were treated topically with furazolidone spray when they developed new corneal ulcers, or when existing lesions worsened during subsequent examination periods (NFZ group). Healing times of the corneal ulcers were reported in 3 ways: the combined times for ulcers present in both eyes of a calf simultaneously (method A), independent times of each ulcer on a calf (method B), and time of the first ulcer for each calf (method C). Censored healing times were examined as left censored (ulcer present at the beginning of the study), right censored (ulcer not healed at the end of the study), or uncensored (true) healing times. The effect that the treatments had on healing times were investigated by use of notched box and whisker plots, life tables, and Cox regression models. The analysis indicated that treatment of calves with either antimicrobial reduced the healing time of corneal ulcers, compared with untreated controls. Calves treated with OTC had shorter periods with ulcers present on both eyes than did NFZ-treated calves. The healing time of the first ulcer on a calf was faster when treated with either antimicrobial than when not treated, but no significant difference between periods for OTC and NFZ treatments was found. Censored healing times were consistently longer than uncensored healing times. Box and whisker plots indicated that both treatments shortened healing times more than those for controls, and OTC shortened healing times more than did NFZ for responses A and B (but not C). Life tables showed that OTC healing times were shorter than those for controls, and NFZ shorter than controls for response B and C (but not A). Cox regression model (for response A) showed a borderline significant difference between times for OTC group and controls, and no significant difference between times for NFZ group and controls.

The antibody responses to the capsular carbohydrate (CC) purified from Pasteurella haemolytica serotype 1 were determined by an ELISA using 135 sera from 6 calves vaccinated with phosphate-buffered saline solution, formalin-killed P haemolytica bacterins, live P haemolytica, or an extract of P haemolytica referred to as carbohydrate-protein subunit (CPS). Calves vaccinated with live P haemolytica, bacterins, or CPS developed serum antibodies to CC. Bacterins containing Freund incomplete adjuvant or Freund complete adjuvant induced higher antibody responses than did bacterins containing aluminum hydroxide. In 4 of 6 experiments, high antibody responses to CC were significantly (P less than 0.05) correlated with resistance to transthoracic challenge exposure with P haemolytica. When calves were challenge exposed with a dose of P haemolytica that was 4.5 times greater than the standard challenge exposure dose or when calves that had been vaccinated with CPS were challenge exposed, antibody responses did not significantly (P greater than 0.05) correlate with resistance to challenge exposure. The amount of serum antibodies to CPS increased significantly (P less than 0.05) when calves were vaccinated with live or killed P haemolytica or with CPS, compared with that in calves given saline solution. In 5 of 6 experiments, correlation between high antibody responses and resistance to challenge exposure was significant (P less than 0.05). The correlation between those variables was not significant (P less than 0.07) for CPS-vaccinated calves. In the ELISA, treatment of CPS with sodium m-periodate, to oxidize periodate-sensitive carbohydrate epitopes, failed to markedly alter the antibody response to CPS. However, the correlation between high antibody responses to periodate-treated CPS and resistance was significant (P less than 0.05) for all 6 experiments. In the ELISA, periodate treatment of CC, lipopolysaccharide, and CPS caused average reductions in antibody reactivity of 7.1%, 53.8%, and 34.5%, respectively. Preadsorption of sera with CC or lipopolysaccharide did not markedly reduce antibody reactivity with CPS. Preadsorption of sera with CC and reaction with periodate-treated and nontreated CPS indicatedthat for calves given phosphate-buffered saline solution vaccines, antibody reactivity was reduced 65.4%, whereas for those vaccinated with a bacterin with aluminum hydroxide, a bacterin with Freund incomplete adjuvant, or live P haemolytica, antibody reactivity was reduced 47.1%, 40.5%, and 25.0%, respectively. It was concluded that serum antibodies to CC are of some importance in resistance and that certain epitopes in CPS that are not sensitive to periodate are of importance in resistance to bovine pneumonic pasteurellosis. There are qualitative and quantitative differences among the serum antibody responses to carbohydrate epitopes for calves vaccinated with phosphate-buffered saline solution, bacterins, or live P haemolytica.

The effect of fungi on the growth of body organs in mice was investigated. Single, intraperitoneal injections of yeasts (Cryptococcus albidus, Saccharomyces cerevisiae, Schizosaccharomyces octosporus) or molds (Aspergillus niger, Geotrichum candidum, Mucor haemalis) induced an increase in the mass of seminal vesicles and coagulating glands independent of whole body weight changes in mice.

Cytoplasmic proteins from unsporulated and sporulated Eimeria maxima oocysts were analyzed by gel-filtration column chromatography. Unsporulated oocysts were characterized as having 3 major cytoplasmic proteins and sporulated oocysts as having 5 major cytoplasmic proteins. Molecular weights ranged from 5 X 10(3) to 1.4 X 10(6). Larger molecular weight proteins were detected in sporulated and unsporulated oocysts, but were associated more with sporocysts of sporulated oocysts.

In vitro activities of 9-([2-hydroxyethoxy] methyl) guanine (acyclovir), (E)-5-(2-bromovinyl)-2'deoxyuridine, 9-beta-D-arabinofuranosyladenine (vidarabine), 5-iodo-2'-deoxyuridine (idoxuridine), and 5-trifluoromethyl-2'-deoxyuridine (trifluridine) were studied against 6 strains of feline herpesvirus-1. A significant difference was not detected among viral strains in their susceptibility to these compounds (P = 0.442). The relative potency of these compounds was trifluridine greater than greater than idoxuridine greater than virdarabine greater than bromovinyldeoxyuridine greater than greater than acyclovir. Concentrations of trifluridine and idoxuridine (0.67 and 6.8 micromole, respectively) required to reduce plaque numbers by 50%, compared with that of controls, were significantly lower (P less than 0.001) than were those of other compounds.